Retatrutide dramatically suppresses appetite through its triple-receptor mechanism
RELATED: GLP-1 agonists: Uses, common brands, and safety info When it comes to the best weight loss medication for PCOS, a 2023 article published in the journal American Family Physician points to Metformin as a first-line treatment for individuals with PCOS who have metabolic issues such as insulin resistance
Retatrutide is a GLP-1/GIP/GCGR agonist that is currently under development
GIP receptor activation has been proposed, based on preclinical and early human data, to further support insulin secretion and fat metabolism, whilst glucagon receptor agonism may promote energy expenditure and reduce hepatic fat accumulation
Patients taking diabetes medications or blood pressure medications should be especially careful because weight loss and appetite changes may alter medication needs
All Lttl microdose plans are FSA and HSA eligible